Selected research
Industry Research
Ambulatory Phlebectomy Industry Research Report 2026
Market perspective
The global Ambulatory Phlebectomy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ambulatory Phlebectomy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ambulatory Phlebectomy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ambulatory Phlebectomy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ambulatory Phlebectomy include Medtronic, Boston Scientific, BD, AngioDynamics, Teleflex, Biolitec AG, B. Braun, Merit Medical and Dornier MedTech and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ambulatory Phlebectomy market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ambulatory Phlebectomy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ambulatory Phlebectomy Market by Company
Medtronic
Boston Scientific
BD
AngioDynamics
Teleflex
Biolitec AG
B. Braun
Merit Medical
Dornier MedTech
Alma Lasers
Ambulatory Phlebectomy Segment by Type
Traditional Ambulatory Phlebectomy
Transilluminated Powered Phlebectomy (TIPP)
Combined Procedure
Ambulatory Phlebectomy Segment by Application
Hospital
Specialized Vein Clinics
Aesthetic Clinics
Ambulatory Phlebectomy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Phlebectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Phlebectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Phlebectomy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ambulatory Phlebectomy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional Ambulatory Phlebectomy
- Transilluminated Powered Phlebectomy (TIPP)
- Combined Procedure
Applications
- Hospital
- Specialized Vein Clinics
- Aesthetic Clinics
Companies covered
- Medtronic
- Boston Scientific
- BD
- AngioDynamics
- Teleflex
- Biolitec AG
- B. Braun
- Merit Medical
- Dornier MedTech
- Alma Lasers
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ambulatory Phlebectomy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Traditional Ambulatory Phlebectomy
- 2.2.3 Transilluminated Powered Phlebectomy (TIPP)
- 2.2.4 Combined Procedure
- 2.3 Ambulatory Phlebectomy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Specialized Vein Clinics
- 2.3.4 Aesthetic Clinics
- 2.4 Assumptions and Limitations
3 Ambulatory Phlebectomy Breakdown Data by Type
- 3.1 Global Ambulatory Phlebectomy Historic Market Size by Type (2021-2026)
- 3.2 Global Ambulatory Phlebectomy Forecasted Market Size by Type (2027-2032)
4 Ambulatory Phlebectomy Breakdown Data by Application
- 4.1 Global Ambulatory Phlebectomy Historic Market Size by Application (2021-2026)
- 4.2 Global Ambulatory Phlebectomy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ambulatory Phlebectomy Market Perspective (2021-2032)
- 5.2 Global Ambulatory Phlebectomy Growth Trends by Region
- 5.2.1 Global Ambulatory Phlebectomy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ambulatory Phlebectomy Historic Market Size by Region (2021-2026)
- 5.2.3 Ambulatory Phlebectomy Forecasted Market Size by Region (2027-2032)
- 5.3 Ambulatory Phlebectomy Market Dynamics
- 5.3.1 Ambulatory Phlebectomy Industry Trends
- 5.3.2 Ambulatory Phlebectomy Market Drivers
- 5.3.3 Ambulatory Phlebectomy Market Challenges
- 5.3.4 Ambulatory Phlebectomy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ambulatory Phlebectomy Players by Revenue
- 6.1.1 Global Top Ambulatory Phlebectomy Players by Revenue (2021-2026)
- 6.1.2 Global Ambulatory Phlebectomy Revenue Market Share by Players (2021-2026)
- 6.2 Global Ambulatory Phlebectomy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ambulatory Phlebectomy Head Office and Area Served
- 6.4 Global Ambulatory Phlebectomy Players, Product Type & Application
- 6.5 Global Ambulatory Phlebectomy Manufacturers Established Date
- 6.6 Global Ambulatory Phlebectomy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ambulatory Phlebectomy Market Size (2021-2032)
- 7.2 North America Ambulatory Phlebectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ambulatory Phlebectomy Market Size by Country (2021-2026)
- 7.4 North America Ambulatory Phlebectomy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ambulatory Phlebectomy Market Size (2021-2032)
- 8.2 Europe Ambulatory Phlebectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ambulatory Phlebectomy Market Size by Country (2021-2026)
- 8.4 Europe Ambulatory Phlebectomy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ambulatory Phlebectomy Market Size (2021-2032)
- 9.2 Asia-Pacific Ambulatory Phlebectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ambulatory Phlebectomy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ambulatory Phlebectomy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ambulatory Phlebectomy Market Size (2021-2032)
- 10.2 South America Ambulatory Phlebectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ambulatory Phlebectomy Market Size by Country (2021-2026)
- 10.4 South America Ambulatory Phlebectomy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ambulatory Phlebectomy Market Size (2021-2032)
- 11.2 Middle East & Africa Ambulatory Phlebectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ambulatory Phlebectomy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ambulatory Phlebectomy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.1.4 Medtronic Ambulatory Phlebectomy Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Boston Scientific
- 12.2.1 Boston Scientific Company Information
- 12.2.2 Boston Scientific Business Overview
- 12.2.3 Boston Scientific Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.2.4 Boston Scientific Ambulatory Phlebectomy Product Portfolio
- 12.2.5 Boston Scientific Recent Developments
- 12.3 BD
- 12.3.1 BD Company Information
- 12.3.2 BD Business Overview
- 12.3.3 BD Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.3.4 BD Ambulatory Phlebectomy Product Portfolio
- 12.3.5 BD Recent Developments
- 12.4 AngioDynamics
- 12.4.1 AngioDynamics Company Information
- 12.4.2 AngioDynamics Business Overview
- 12.4.3 AngioDynamics Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.4.4 AngioDynamics Ambulatory Phlebectomy Product Portfolio
- 12.4.5 AngioDynamics Recent Developments
- 12.5 Teleflex
- 12.5.1 Teleflex Company Information
- 12.5.2 Teleflex Business Overview
- 12.5.3 Teleflex Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.5.4 Teleflex Ambulatory Phlebectomy Product Portfolio
- 12.5.5 Teleflex Recent Developments
- 12.6 Biolitec AG
- 12.6.1 Biolitec AG Company Information
- 12.6.2 Biolitec AG Business Overview
- 12.6.3 Biolitec AG Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.6.4 Biolitec AG Ambulatory Phlebectomy Product Portfolio
- 12.6.5 Biolitec AG Recent Developments
- 12.7 B. Braun
- 12.7.1 B. Braun Company Information
- 12.7.2 B. Braun Business Overview
- 12.7.3 B. Braun Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.7.4 B. Braun Ambulatory Phlebectomy Product Portfolio
- 12.7.5 B. Braun Recent Developments
- 12.8 Merit Medical
- 12.8.1 Merit Medical Company Information
- 12.8.2 Merit Medical Business Overview
- 12.8.3 Merit Medical Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.8.4 Merit Medical Ambulatory Phlebectomy Product Portfolio
- 12.8.5 Merit Medical Recent Developments
- 12.9 Dornier MedTech
- 12.9.1 Dornier MedTech Company Information
- 12.9.2 Dornier MedTech Business Overview
- 12.9.3 Dornier MedTech Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.9.4 Dornier MedTech Ambulatory Phlebectomy Product Portfolio
- 12.9.5 Dornier MedTech Recent Developments
- 12.10 Alma Lasers
- 12.10.1 Alma Lasers Company Information
- 12.10.2 Alma Lasers Business Overview
- 12.10.3 Alma Lasers Revenue in Ambulatory Phlebectomy Business (2021-2026)
- 12.10.4 Alma Lasers Ambulatory Phlebectomy Product Portfolio
- 12.10.5 Alma Lasers Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst